NCT05468164View on ClinicalTrials.gov

A Study of Effect of Food and a Proton Pump Inhibitor on Selpercatinib (LY3527723) in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

May 31, 2018

Primary Completion Date

September 13, 2018

Study Completion Date

September 13, 2018

Conditions

Healthy

Interventions

DRUG

Selpercatinib

Administered orally

DRUG

Omeprazole

Administered orally

Trial Locations (1)

85283

Celerion, Tempe

Sponsors

Collaborators (1)

Loxo Oncology, Inc.

All Listed Sponsors

collaborator

Loxo Oncology, Inc.

INDUSTRY

lead

Eli Lilly and Company

INDUSTRY

NCT05468164 - A Study of Effect of Food and a Proton Pump Inhibitor on Selpercatinib (LY3527723) in Healthy Participants | Biotech Hunter | Biotech Hunter